CYCC 13D/13G Filings - Cyclacel Pharmaceuticals Inc.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2021-03-18 12:59 pm Purchase	2021-03-12	13G	Cyclacel Pharmaceuticals, Inc. CYCC	SPHERA FUNDS MANAGEMENT LTD.	2,112 6.290%	2,112 (New Position)	Filing History
2021-02-16 09:57 am Purchase	2020-12-31	13G	Cyclacel Pharmaceuticals, Inc. CYCC	CVI Investments, Inc.	1,171 4.900%	5 (+0.46%)	Filing History
2021-02-12 4:58 pm Purchase	2020-12-18	13G	Cyclacel Pharmaceuticals, Inc. CYCC	ACORN BIOVENTURES, L.P.	9,769 9.990%	9,769 (New Position)	Filing History
2021-02-11 09:41 am Unchanged	2020-12-31	13G	Cyclacel Pharmaceuticals, Inc. CYCC	Renaissance Technologies LLC	0 0.000%	0 (Unchanged)	Filing History
2021-02-09 2:28 pm Purchase	2020-12-31	13G	Cyclacel Pharmaceuticals, Inc. CYCC	Hudson Bay Capital Management LP	1,719 7.160%	1,719 (New Position)	Filing History
2021-01-08 9:59 pm Purchase	2020-12-23	13G	Cyclacel Pharmaceuticals, Inc. CYCC	Ikarian Capital, LLC	1,667 8.200%	1,667 (New Position)	Filing History
2020-12-28 3:02 pm Purchase	2020-12-22	13G	Cyclacel Pharmaceuticals, Inc. CYCC	PURA VIDA INVESTMENTS LLC	1,979 8.880%	1,979 (New Position)	Filing History
2020-12-23 4:42 pm Purchase	2020-12-23	13G	Cyclacel Pharmaceuticals, Inc. CYCC	Aspire Capital Fund LLC	1,125 5.050%	1,125 (New Position)	Filing History

Goto Prev, 0, 1